SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-19-013962
Filing Date
2019-04-30
Accepted
2019-04-30 06:49:49
Documents
2
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A reta-defa14a_20190228.htm DEFA14A 25799
2 GRAPHIC gowlwded0w3c000001.jpg GRAPHIC 109419
  Complete submission text file 0001564590-19-013962.txt   177623
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37785 | Film No.: 19778334
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences